Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 14, 2021
Detection of active mycobacterium tuberculosis at 6th month exit among declared successfully treated cases in PakistanArslan Ahmed Salam, Sabira Tahseen, Rabail Javed, et al.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|June 10, 2023
National Cancer Registry of Pakistan: First Comprehensive Report of Cancer Statistics 2015-2019Aamer Ikram, Shahid Pervez, Muhammad Tahir Khadim, et al.
Expert Review of Anti-Infective Therapy|May 26, 2021
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implicationsZikria Saleem, Brian Godman, Faiza Azhar, et al.
JMIR Public Health and Surveillance|November 4, 2021
Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: Multicountry Retrospective StudyFaris Lami, Maisa Elfadul, Hiba Rashak, et al.
JMIR Public Health and Surveillance|March 8, 2019
Innovative Approaches to Improve Public Health Practice in the Eastern Mediterranean Region: Findings From the Sixth Eastern Mediterranean Public Health Network Regional ConferenceBashiruddin Noormal, Elmuez Eltayeb, Mohannad Al Nsour, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2021
An Epidemic of Pediatric HIV From Reuse of Infusion Equipment in PakistanMuhammad Asif Syed, Adnan Khan, Ambreen Chaudhry, et al.
The Lancet Regional Health. Southeast Asia|January 18, 2024
Environmental surveillance for COVID-19 using SARS-CoV-2 RNA concentration in wastewater - a study in District East, Karachi, PakistanNadia Ansari, Furqan Kabir, Waqasuddin Khan, et al.
Narra J|March 7, 2024
Acceptance and willingness to purchase a hypothetical COVID-19 vaccine in a region under Shariah law: A cross-sectional study in Aceh, IndonesiaMuhammad A Rayhan, Mudatsir Mudatsir, Nurjannah Nurjannah, et al.
Vaccine|March 21, 2026
Relative efficacy, safety, and immunogenicity analysis of two doses versus one dose of recombinant coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomized, double blinded phase 3 trialAdora Rooyakkers, Lingyun Ye, Pedro E Cahn, et al.
Lancet (London, England)|December 26, 2021
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trialScott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, et al.
Pageof 16